Free press releases distribution network?

Agency / Source: Inter-Dev Internet Marketing

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Drug Development Company Do-Coop Technologies Ltd Introduces Innovative Patented Nanotechnology System - Neowater® - An innovative patented Nanotechnology system has been developed by a Drug Development Company located in Israel. This technology has brought the drug development process into a completely new level
Drug Development Company Do-Coop Technologies Ltd Introduces Innovative Patented Nanotechnology System

 

PRZOOM - /newswire/ - Or Yehuda, Israel, 2008/10/29 - Neowater® - An innovative patented Nanotechnology system has been developed by a Drug Development Company located in Israel. This technology has brought the drug development process into a completely new level.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Pathogens evolve every day, and hence challenges met by the worldwide health care centers are tremendous. Therefore, one has to keep up with these fast and efficient techniques to identify infections as early as possible.

Do-coop Technologies Ltd. is a private company established in 1997 in Israel near Tel Aviv close to the Ben-Gurion International Airport. It has developed a patented Nanotechnology system to modify the properties of water using nanometer (one-billionth of a meter) size particles (Nano particles). This enables the first ever introduction of water-based biomaterials.

Neowater® is the first branded product of Do-coop, which targets the molecular diagnostics and research market within the Life Science industry. It is also offering new soluble service for Pharma and Biotech companies to enhance bioavailability and solubility of existing and new drugs. Do-coop qualifies for ISO 9001:2000 and ISO 14001:2004. The Neowater® technology is generated using a distinctive and innovated patented-process, challenges, and contemporary notions about water as well as the fundamental understanding of modern Physics.

Do-coop has the required proficiencies in the fields of Nanotechnology, Chemistry, Physics, and Biology. Neowater® has developed exceptional and half step PCR based kits for a rapid and consistent identification of various avian, feline and canine disease tests.

These kits are freeze free thus, the expense of shipping and storing are reduced, as it can be stored at room temperature. The diagnostic company such as Karnieli Ltd. presently uses Neowater®. To know more about Neowater® log on to the website. If you have queries or question you can log on to this site and you will receive a prompt reply from docoop.com. Docoop.com lets you know all the necessary information related to their current projects and services to other companies and detailed reports, supports, forums and media details.

Everyone loves to have a life of quality. Technology does go a long way in helping lead us a quality life, but sometimes one needs to have a superior technology to solve certain problems. Neowater® is a technology that will help you lead this quality life. On docoop.com, you can also join their research in their field of water physics and chemistry.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Inter-Dev Internet Marketing

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Drug Development Company Do-Coop Technologies Ltd Introduces Innovative Patented Nanotechnology System

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Docoop 
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Inter-Dev Internet Marketing securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Inter-Dev Internet Marketing / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Rapid Recovery

Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today